Virodhamine (OAE)

A fifth endocannabinoid, virodhamine, or O-arachidonoyl-ethanolamine (OAE), was discovered in June 2002. Although it is a full agonist at CB2 and a partial agonist at CB1, it behaves as a CB1 antagonist in vivo. In rats, virodhamine was found to be present at comparable or slightly lower concentrations than anandamide in the brain, but 2- to 9-fold higher concentrations peripherally.
Incorrect API key provided: sk-QKmyT***************************************Xv1G. You can find your API key at https://platform.openai.com/account/api-keys.COVID-19 Cannabis Industry Safety (Free Trial)
Time: 1:01 Hour
eBook: 25 Pages
Quiz: 20 Questions
Grade: 70%+ Required
Cannabis Horticulture (Free Trial)
Time: 32 Minutes
eBook: 10 Pages
Quiz: 15 Questions
Grade: 70%+ Required
Cannabis Delivery Experience (Free Trial)
Time: 56 Minutes
eBook: 18 Pages
Quiz: 20 Questions
Grade: 70%+ Required
12